Indian Army Ophthalmic Mock Tender 2025 Central Delhi Eye Drops & Ointments Procurement - Timolol, Gatifloxacin, Prednisolone 2025

Tender Overview

The Indian Army (Department Of Military Affairs) invites bids for a broad spectrum of ophthalmic products, including acyclovir ophthalmic ointment, timolol maleate preservative-free solutions, ciprofloxacin with dexamethasone, cyclosporine eye drops, fluconazole eye solutions, ketorolac, brimonidine, loteprednol, dorzolamide, ofloxacin, prednisolone acetate, and sodium chromoglycate eye drops. The procurement is anchored in a centralized military medical framework for use in Central Delhi, with 15 listed items forming the core salable pack. The scope appears to cover multiple 5 ml/3 ml bottles and 5 ml eye drops with defined per cent strengths (e.g., 0.5%, 0.3%, 0.1%, 0.05%, 0.4%). The contract pricing must accommodate an option clause enabling up to 25% additional quantity at contract rates. The emphasis is on ready-to-stock ophthalmic formulations suitable for military clinical use.

• Organization: Indian Army, Department Of Military Affairs
• Location: CENTRAL DELHI, DELHI - 110002
• Category: Ophthalmic products (eye drops and ointments) in fixed concentrations
• Quantity/Value context: 15 items with potential quantity flex (up to 25% both initially and during contract)
• Unique features: Option clause enables scale-up at same rates; delivery clock starts after the original delivery order
• Context: Aligns with military medical supply chain standards and rapid fulfillment for field hospitals and military clinics

Technical Specifications & Requirements

• Eye care portfolio includes: Acyclovir Ophthalmic Ointment 3% w/w in 5 g tube, Timolol Maleate 0.5% Preservative Free (Comod System), Ciprofloxacin HCl 0.3% with Dexamethasone eye drops 0.1% Bottles 5 ml, Cyclosporine eye drops 0.05% in 3 ml bottles, Fluconazole 0.3% in 5 ml bottles, Flurbiprofen Sodium ophthalmic solution 0.3% in 5 ml vial, Gatifloxacin 0.3% in 5 ml eye drop bottles, Homotropine hydrochloride, Ketorolac Tromethamine 0.4% eye drops, Brimonidine Tartrate 0.2% eye drops, Loteprednol Etabonate 0.5% in 5 ml bottles, Dorzolamide 2% eye drops, Ofloxacin 0.3% in 5 ml bottles (ED), Prednisolone acetate 1% in 5 ml bottles, Sodium Chromoglycate eye drops 2% in 5 ml bottles.
• No explicit technical performance specs, testing methods, or packaging standards are published in the tender data.
• The BOQ lists 15 items but provides no unit quantities, values, or delivery locations beyond central Delhi; bidders should prepare to align with general ophthalmic pharmaceutical distribution requirements and military-grade quality control.
• The terms emphasize the option quantity clause and delivery timing mechanics defined in the Buyer Added Terms clause.

Terms, Conditions & Eligibility

• EMD/Performance terms: Not explicitly stated in the data; bidders must rely on standard Army procurement deposits and performance security per tender policy.
• Delivery timeline: Delivery start tied to original delivery order; additional time for option quantities calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days; extended delivery permitted with contract alignment.
• Option clause: Up to 25% increase in order quantity initially and during contract currency at contracted rates.
• Documentation requirements: Mandatory submission of standard government tender documents, including GST registration, PAN, experience certificates, and financial statements; OEM authorization may be required for ophthalmic products.
• Audit/ATC: An ATC document may have been uploaded by the buyer; bidders should review and comply with that file.
• Vendor due diligence: Compliance with central Delhi procurement norms and Department of Military Affairs guidelines for pharmaceutical products.
• Warranty & penalties: Not detailed in the available data; bidders should anticipate standard warranty and LD structures as per Army procurement norms.
• Compliance posture: Suppliers should demonstrate capability to supply multiple ophthalmic formulations with sterile packaging and quality assurance aligned to medical standards.